2.0
Apr 6, 2025
Recommend
CEO approval
Business Outlook
Pros
It's a CDMO. It's pharma. You can learn about CDMOs and pharma overall to get some experience under your belt.
Cons
Benefits are so-so. Not much better than other pharma companies. IT is scattered too much, and not willing to make investments to improve, just maintain. It's not a startup anymore. Too much change and a significant reduction in headcount this year. Catalent is on shaky ground now.